The purpose of this study is to determine target dose range of buprenorphine/naloxone
combination tablet that provides therapeutic response in opiate addicts with low to moderate
dependence, and to identify appropriate initial induction dose in opiate addicts with low to
moderate dependence."
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Naloxone